Eledon Pharmaceuticals, Inc. (ELDN) Misses Q1 EPS by 2c

Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) reported Q1 EPS of ($0.34), $0.02 worse than the analyst estimate of ($0.32).

For earnings history and earnings-related data on Eledon Pharmaceuticals, Inc. (ELDN) click here.

You May Also Be Interested In

• After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
• Ulta Beauty (ULTA) Tops Q2 EPS by 38c, Offers Outlook
• Marvell Technology (MRVL) Tops Q2 EPS by 1c, Offers Guidance